Philip Vickers

Philip Vickers

Director/Miembro de la Junta en AKEBIA THERAPEUTICS, INC. .
66 años
Health Technology
Commercial Services
Consumer Services

Perfil

Philip J.
Vickers
currently serves as President, Chief Executive Officer & Director at Solu Therapeutics, Inc., Director at Northern Mosaic LP, and Director at Akebia Therapeutics, Inc. (starting 2026).
Former roles include President, Chief Executive Officer & Director at Northern Biologics, Inc. (2017–2020), President, Chief Executive Officer & Director at Faze Medicines, Inc. (2021–2022), President, Director & Chief Scientific Officer at Resolvyx Pharmaceuticals, Inc. (2009–2011), Independent Director at Revance Therapeutics, Inc. (2015–2023), Director at Neusentis Ltd., Independent Director at AVROBIO, Inc. (2019–2024), Global Head-Research & Development at Shire Plc (2013–2017), Principal at Boehringer Ingelheim Corp., VP & Head-Pfizer Research Technology Center at Pfizer (St. Louis), and Principal at Merck Research Laboratories Massachusetts LLC.
Education includes undergraduate studies at the University of Salford and a doctorate from the University of Toronto.

Cargos activos de Philip Vickers

EmpresasCargoInicio
AKEBIA THERAPEUTICS, INC. Director/Miembro de la Junta 01/04/2026
Director/Miembro de la Junta -
Director Ejecutivo 01/09/2023

Antiguos cargos conocidos de Philip Vickers.

EmpresasCargoFin
TECTONIC THERAPEUTIC, INC. Director/Miembro de la Junta 20/05/2024
REVANCE THERAPEUTICS, INC. Director/Miembro de la Junta 03/05/2023
Director Ejecutivo 01/11/2022
Director Ejecutivo 01/12/2020
SHIRE Director Técnico/Científico/I+D 01/06/2017
Ver el detalle de la experiencia de Philip Vickers.

Formación de Philip Vickers.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

66

Relaciones de 1er grado

15

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas15

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Services

Health Technology

Commercial Services

Commercial Services

Health Technology